ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Clinical benefits and side effects of ipilimumab in melanoma patients
Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy
Molecular chaperones: cancer dependence and druggability
Prof Paul Workman - The Institute of Cancer Research, Sutton, UK
World Health Organisation cancer prevention and control
Dr Andreas Ullrich - World Health Organisation Medical Officer
The European Academy of Cancer Sciences
Prof Alexander Eggermont and Prof Anton Berns
ESTRO 2010 - Snapshots from the conference
European Society for Therapeutic Radiology and Oncology meeting, Barcelona, 12-1...
ESTRO 2010 Highlights
Professor Gordon McVie - European Institute of Oncology
The role of the B-RAF mutation in melanoma treatment
Prof Richard Marais - Institute of Cancer Research, London, UK
Biotherapy Development Association
Prof Heinz Zwierzina - Innsbruck Medical University, Austria
Advances in melanoma treatment
Prof John Wagstaff - University of Swansea, Wales
Advances in the treatment of melanoma
Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands
Roundup of the 2010 ASCO conference
Prof Gordon McVie - European Institute of Oncology, Milan
Antibody drug ipilimumab improves long-term survival in previously treated advan...
Dr Steven O'Day - The Angeles Clinic and Research Institute, Santa Monica, Calif...